Kidswell Bio (TSE:4584) Growth Rank: 4 (As of Sep. 16, 2026) — 50% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4584 Kidswell Bio Corp TSE:4584
44 GF Score
Price 円160.00
GF Value 円234.04
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Kidswell Bio Growth Rank?

Kidswell Bio TSE:4584 -3.03% 44 Growth Rank is 4 as of Sep. 16, 2026, which is 50% below its 10-year median of 8.00. GuruFocus rates TSE:4584 with a GF Score™ of 44/100 and a GF Value™ of 円234.04 (Possible Value Trap). The stock has 6 warning signs investors should review.

Kidswell Bio has the Growth Rank of 4.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

TSE:4584 vs VRTX, REGN, MRNA: Growth Rank Comparison

For the Biotechnology subindustry, Kidswell Bio's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kidswell Bio Growth Rank vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kidswell Bio's Growth Rank distribution charts can be found below:

* The bar in red indicates where Kidswell Bio's Growth Rank falls into.


TSE:4584
44GF Score
Kidswell Bio Corp TSE:4584
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 4 mean?
Kidswell Bio (TSE:4584) has a Growth Rank of 4 as of Sep. 16, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Kidswell Bio and its competitors. This is 50% below median its historical median of 8.00. Over the past decade, Kidswell Bio's Growth Rank has ranged from 4.00 to 10.00.
Is Kidswell Bio's Growth Rank too high?
Kidswell Bio's current Growth Rank of 4 is 50% below median its 10-year median of 8.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 10.00. Overall, Kidswell Bio has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kidswell Bio's Growth Rank compare to VRTX and REGN?
Kidswell Bio's Growth Rank of 4 can be compared against companies in the Biotechnology industry. Historically, Kidswell Bio's own Growth Rank has ranged from 4.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Biotechnology company?
A good Growth Rank depends on the Biotechnology industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Kidswell Bio and its competitors. Kidswell Bio's current Growth Rank is 4, which is 50% below median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kidswell Bio stock overvalued right now?
Based on GuruFocus' analysis, Kidswell Bio (TSE:4584) is currently considered Possible Value Trap. The stock's GF Value™ is 円234.04, compared to a current price of 円160.00 — trading 31.6% below its estimated fair value. The current Growth Rank is 4, which is 50% below median its 10-year median of 8.00. Kidswell Bio's overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Kidswell Bio (TSE:4584), the current Growth Rank is 4 as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kidswell Bio (TSE:4584) Overvalued in 2026?

Based on GuruFocus' analysis, Kidswell Bio stock appears to be undervalued. The current stock price of 円160.00 is trading 31.6% below its estimated GF Value™ of 円234.04. GuruFocus considers Kidswell Bio to be Possible Value Trap.

Key valuation signals for TSE:4584:

  • Growth Rank: 4 (50% below median its 10-year median of 8.00)
  • GF Value™: 円234.04 vs. price of 円160.00 (31.6% below fair value)
  • GF Score™: 44/100 with 6 warning signs

No single metric tells the full story. See the TSE:4584 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kidswell Bio Business Description

Address 1-2-12, Shinkawa, Kanayama Building, 3rd Floor, Chuo-ku, Tokyo, JPN, 104-0033
Kidswell Bio Corp is a biopharmaceutical company engaged in the discovery and development of drugs.
44GF Score

Get the complete analysis for TSE:4584

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円160.00
Price
円234.04
GF Value